119th Congress
H.Res. 803
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
- Introduced
- In committee
- Agreed to
- Sponsor
- John W. Rose(R-TN)
- Introduced
- Oct 10, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (11)
Original cosponsors (7)
- Barry Moore (R-AL)
- Diana Harshbarger (R-TN)
- Earl L. "Buddy" Carter (R-GA)
- Glenn Grothman (R-WI)
- Harriet M. Hageman (R-WY)
- Sheri Biggs (R-SC)
- L000578
Added later (4)
- Robert B. Aderholt (R-AL) · Oct 17, 2025
- Andy Harris (R-MD) · Oct 28, 2025
- Ben Cline (R-VA) · Nov 4, 2025
- Michael Guest (R-MS) · Nov 4, 2025
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Latest action(Oct 10, 2025): Referred to the House Committee on Energy and Commerce.
Roll-call votes
No recorded votes on this bill.
Actions
- Oct 10, 2025 · House
Referred to the House Committee on Energy and Commerce. - Oct 10, 2025
Submitted in House